Simcere Pharmaceutical Group Limited Share Price
Stocks
2096
HK0000658531
Pharmaceuticals
OTC Markets Traded|
Delayed
Hong Kong S.E.
08:10:29 17/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 11.28 HKD | +0.98% |
|
+0.53% | -5.76% |
| 04/09 | Simcere Pharma's Yingmule Gets China Marketing Approval for RSV Prevention | MT |
| 03/09 | Simcere Pharmaceutical Group Limited Announces Approval for Marketing of Yingmule in China | CI |
| Market Cap | 365.68Cr 2.87TCr 316.89Cr 299.52Cr 271.92Cr 509.63Cr 35TCr 512.68Cr 3.58TCr 1.38TCr 18TCr 1.37TCr 1.34TCr 57TCr | P/E 2026 * |
13.9x | P/E 2027 * | 12.1x |
|---|---|---|---|---|---|
| Enterprise Value | 345.95Cr 2.71TCr 299.8Cr 283.36Cr 257.25Cr 482.13Cr 33TCr 485.02Cr 3.38TCr 1.31TCr 17TCr 1.3TCr 1.27TCr 54TCr | EV / Sales 2026 * |
2.3x | EV / Sales 2027 * | 2.08x |
| Free-Float |
32.13% | Yield 2026 * |
3.77% | Yield 2027 * | 4.28% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 2096 | Delayed | |
OTC Markets
| SMHGF | Delayed | |
|
Tradegate
| S2P | Real-time | |
|
Deutsche Boerse AG
| S2P | Delayed | |
|
Börse Stuttgart
| S2P | Delayed | |
|
Boerse Muenchen
| S2P | Real-time |
| 1 day | +0.98% | ||
| 1 week | +0.53% | ||
| Current month | +1.62% | ||
| 1 month | -8.81% | ||
| 3 months | +19.49% | ||
| 6 months | -6.08% | ||
| Current year | -5.76% |
| 1 week | 10.92 |  | 11.5 |
| 1 month | 10.92 | | 12.82 |
| Current year | 9.07 | | 14.28 |
| 1 year | 9.07 | | 14.38 |
| 3 years | 4.94 | | 15.08 |
| 5 years | 4.94 | | 15.08 |
| 10 years | 4.94 | | 15.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CEO | Chief Executive Officer | 63 | 20/08/2026 |
Yunshu Zhou
CEO | Chief Executive Officer | 54 | 25/03/2026 |
Yushan Wan
DFI | Director of Finance/CFO | 55 | 19/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Jinsheng Ren
CHM | Chairman | 63 | 08/10/2012 |
Yushan Wan
BRD | Director/Board Member | 55 | 19/11/2019 |
Renhong Tang
BRD | Director/Board Member | 46 | 01/11/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/08/26 | Other | Chairperson | -30,00,000 | 0.1168% | ||
| 13/07/26 | Other | Founder | -47,000 | 0.0018% | ||
| 13/07/26 | Other | Director | -47,000 | 0.0018% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.98% | +0.53% | -13.76% | +70.91% | 368.31Cr | |
| +1.01% | -0.61% | +15.09% | +61.20% | 4.59TCr | |
| +3.12% | -1.92% | +38.20% | +101.89% | 3.87TCr | |
| +0.77% | -1.77% | +7.06% | +71.61% | 1.14TCr | |
| +0.52% | -0.37% | -12.89% | +9.92% | 1.14TCr | |
| +0.96% | +0.57% | +19.32% | +148.82% | 908.8Cr | |
| -0.47% | +0.16% | +27.34% | +36.96% | 729.75Cr | |
| +2.17% | +1.58% | +39.21% | -18.66% | 712.96Cr | |
| +1.61% | -1.03% | +16.03% | +181.38% | 697.73Cr | |
| +0.61% | -5.43% | -43.52% | +5.23% | 488.51Cr | |
| Average | +1.13% | -1.89% | +9.21% | +66.92% | 1.46TCr | |
| Weighted average by Cap. | +1.50% | -2.53% | +17.80% | +73.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 150.16Cr 1.18TCr 130.13Cr 122.99Cr 111.66Cr 209.27Cr 14TCr 210.52Cr 1.47TCr 567.36Cr 7.31TCr 564.07Cr 551.55Cr 23TCr | 169.25Cr 1.33TCr 146.67Cr 138.63Cr 125.85Cr 235.88Cr 16TCr 237.29Cr 1.65TCr 639.49Cr 8.24TCr 635.78Cr 621.67Cr 26TCr |
| Net income | 26Cr 200.31Cr 22Cr 21Cr 19Cr 36Cr 2.45TCr 36Cr 249.68Cr 96Cr 1.24TCr 96Cr 94Cr 3.96TCr | 30Cr 236.73Cr 26Cr 25Cr 22Cr 42Cr 2.89TCr 42Cr 295.07Cr 114.02Cr 1.47TCr 113.36Cr 110.84Cr 4.68TCr |
| Net Debt | -20Cr -154.78Cr -17Cr -16Cr -15Cr -27Cr -1.89TCr -28Cr -192.93Cr -75Cr -960.05Cr -74Cr -72Cr -3.06TCr | -14Cr -109.63Cr -12Cr -11Cr -10Cr -19Cr -1.34TCr -20Cr -136.64Cr -53Cr -679.95Cr -52Cr -51Cr -2.17TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | HK$11.28 | +0.98% | 6,91,472 |
| 16/26/16 | HK$11.17 | -0.71% | 27,16,666 |
| 15/26/15 | HK$11.25 | -1.23% | 23,23,000 |
| 14/26/14 | HK$11.39 | +3.08% | 72,11,232 |
| 11/26/11 | HK$11.05 | -1.52% | 77,63,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 2096 Stock
Select your edition
All financial news and data tailored to specific country editions
